www.jftc.go.jp/houdou/pressrelease/2025/may/250528kiketesu_st.html
archives
This URL has 1 public saves. The first save was Apr 4, 2026, 12:17 AM and the latest save was Apr 4, 2026, 12:17 AM.
View recent saves on this domain
Latest saved version
(令和7年5月28日)塩野義製薬株式会社による鳥居薬品株式会社等の医薬事業の統合に関する審査結果について | 公正取引委員会
This is the newest public snapshot for this URL and the best place to start reviewing the page.
Source URL
https://www.jftc.go.jp/houdou/pressrelease/2025/may/250528kiketesu_st.html
About this page
This page announces the Fair Trade Commission's examination results regarding Shionogi Pharmaceutical's acquisition of Torii Pharmaceutical and Japan Tobacco's pharmaceutical business division, released May 28, 2025. After reviewing filings under the Antimonopoly Act, the FTC determined that the integration would not substantially restrict competition in relevant markets, provided the companies implement proposed remedial measures. Consequently, no cease-and-desist order was issued. Detailed examination results are available in supplementary materials.
Saved versions
www.jftc.go.jp/houdou/pressrelease/2025/may/250528kiketesu_st.html web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.